Clinical Trial Update: Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluating the safety and efficacy of P276-00 in combination with radiation for advanced head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of Head and Neck

Drugs mentioned

• P276-00 (P276-00)

Snippet

Sponsor: Piramal Enterprises Limited | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 1, Phase 2 | Status: COMPLETED